Literature DB >> 19944744

Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system.

Xiaoju Wang1, Huadong Fan, Zheng Ying, Bin Li, Hongfeng Wang, Guanghui Wang.   

Abstract

TAR DNA-binding protein-43 (TDP-43) is a nuclear protein functioning in the regulation of transcription and mRNA splicing. TDP-43 is accumulated in ubiquitinated inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS) diseased brains. However, the pathways involved in the clearance of TDP-43 and its pathogenic form (TDP-25), a truncated form of TDP-43, are still not elucidated. In this study, we demonstrated that the protein levels of TDP-43 and TDP-25 were increased in cells treated with a proteasome inhibitor, MG132, or an autophagy inhibitor, 3-MA, whereas, they were decreased in cells treated with an enhancer of autophagy, trehalose. Furthermore, more protein level changes of TDP-25 than TDP-43 were observed in cells treated with above inhibitors or enhancer. Thus, our data suggest that TDP-43 and TDP-25 are degraded by both proteasome and autophagy with TDP-25 being more regulated. (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944744     DOI: 10.1016/j.neulet.2009.11.055

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  101 in total

Review 1.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

Review 2.  The Autophagy Lysosomal Pathway and Neurodegeneration.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

3.  Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin.

Authors:  Fenghua Hu; Thihan Padukkavidana; Christian B Vægter; Owen A Brady; Yanqiu Zheng; Ian R Mackenzie; Howard H Feldman; Anders Nykjaer; Stephen M Strittmatter
Journal:  Neuron       Date:  2010-11-18       Impact factor: 17.173

Review 4.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

5.  Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines.

Authors:  Joel A Cassel; Allen B Reitz
Journal:  Biochim Biophys Acta       Date:  2013-03-27

6.  Regulation of autophagy by neuropathological protein TDP-43.

Authors:  Jayarama Krishnan Bose; Chi-Chen Huang; C-K James Shen
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

Review 7.  Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.

Authors:  Wesley Peng; Georgia Minakaki; Maria Nguyen; Dimitri Krainc
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

8.  Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis.

Authors:  Yoshitaka Tashiro; Makoto Urushitani; Haruhisa Inoue; Masato Koike; Yasuo Uchiyama; Masaaki Komatsu; Keiji Tanaka; Maya Yamazaki; Manabu Abe; Hidemi Misawa; Kenji Sakimura; Hidefumi Ito; Ryosuke Takahashi
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  Astrocytic TDP-43 pathology in Alexander disease.

Authors:  Adam K Walker; Christine M LaPash Daniels; James E Goldman; John Q Trojanowski; Virginia M-Y Lee; Albee Messing
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

10.  Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments.

Authors:  Yong-Jie Zhang; Tania F Gendron; Ya-Fei Xu; Li-Wen Ko; Shu-Hui Yen; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2010-08-30       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.